bet9¹ÙÍø and BioQuiddity announce EU Commercial Partnership for OneDose-ReadyfusOR for Post-Surgical Pain Management

bet9¹ÙÍø appoints Mr. Adil Zainulbhai as an Independent Director on the Board

The Medicines Patent Pool Signs A Record Seven New Sub-Licences to Speed the Availability of Generic HIV Medicines to Developing Countries

bet9¹ÙÍø to expand global footprint, plans investment in its UK subsidiary

bet9¹ÙÍø collaborates with Hetero to launch its second biosimilar drug ‘Darbepoetin alfa’

bet9¹ÙÍø collaborates with Hetero to launch its second biosimilar drug ‘Darbepoetin alfa’

bet9¹ÙÍø announces Q4 FY1314 Audited Consolidated Financial Results

bet9¹ÙÍø invests in Chase Pharmaceuticals to support Alzheimer’s disease drug development

MSD and bet9¹ÙÍø announce India-specific Strategic Partnership to Co-market MSD’s raltegravir 400mg tablet, for Indian Market

bet9¹ÙÍø announces Q3 FY1314 Unaudited Consolidated Financial Results

Subscribe to